Showing results (21-30 of 238) with videos related to
Sort By:
Pageof 24
Archives of Neurology|August 11, 2010
A phase 3, double-blind, placebo-controlled trial of idebenone in friedreich ataxiaDavid R Lynch, Susan L Perlman, Thomas MeierNeurodegenerative Disease Management|January 15, 2025
Friedreich ataxia: what can we learn from non-GAA repeat mutations?David R Lynch, M Shen, Robert B WilsonAnnals of Clinical and Translational Neurology|November 26, 2025
Domain Specific Placebo Response in the Modified Friedreich's Ataxia Rating ScaleChristian Rummey, Jennifer M Farmer, David R LynchAmerican Journal of Medical Genetics. Part A|June 27, 2007
Ovarian failure in ataxia with oculomotor apraxia type 2David R Lynch, Corey D Braastad, Narasimhan NaganEclinicalmedicine|January 16, 2020
Predictors of loss of ambulation in Friedreich's ataxiaChristian Rummey, Jennifer M Farmer, David R LynchAnnals of Clinical and Translational Neurology|February 24, 2024
Phenotypic variation of FXN compound heterozygotes in a Friedreich ataxia cohortMegan M Shen, Christian Rummey, David R LynchAnnals of Clinical and Translational Neurology|April 26, 2019
Identification of a novel missense mutation in Friedreich's ataxia -FXNW 168RElisia Clark, Cassandra Strawser, Kimberly Schadt, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 14, 2004
Interactions of postsynaptic density-95 and the NMDA receptor 2 subunit control calpain-mediated cleavage of the NMDA receptorYi Na Dong, Elisa A Waxman, David R LynchNeurodegenerative Disease Management|December 5, 2015
IFN-γ for Friedreich ataxia: present evidenceMcKenzie Wells, Lauren Seyer, Kimberly Schadt, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|January 10, 2014
Glutamatergic autoencephalitides: an emerging fieldJessica A Panzer, Amy J Gleichman, David R LynchPageof 24